ODI Pharma AB publishes the annual report for the fiscal year 2022/2023
The Board of Directors and the Chief Executive Officer of ODI Pharma AB (“ODI Pharma”) hereby publishes the annual report for the fiscal year 2022/2023. The annual report, along with the accompanying auditor’s report, is available as an attached file and on the websites of ODI Pharma (www.odipharma.com) and Spotlight Stock Market (www.spotlightstockmarket.com). A Swedish translation of the annual report is also available on www.odipharma.com.For more information on ODI Pharma, please contact: Derek Simmross, CEO, ODI Pharma AB E-mail: